Sunovion has submitted a New Drug Application for dasotraline, a new treatment for ADHD.
LABA/LAMA is associated with a similar or lower risk of cardiovascular and cerebrovascular adverse events compared to treatment with LABA/inhaled corticosteroid.
Compared with current use of metformin + sulfonylurea, the use of thiazolidinediones + metformin was associated with an increased risk of community-acquired pneumonia.
NSAID use during ARI was associated with a 3.4-fold increased risk of AMI compared with 2.7-fold increased risk without NSAID use.
Only 10% of Medicare beneficiaries were receiving biologic treatments for psoriasis.